HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Wolfgang H Oertel Selected Research

tolcapone (Tasmar)

1/2014Safety and efficacy of tolcapone in the long-term use in Parkinson disease: an observational study.
5/2010Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
1/2008Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Wolfgang H Oertel Research Topics

Disease

57Parkinson Disease (Parkinson's Disease)
09/2015 - 01/2002
17Restless Legs Syndrome (Restless Legs)
08/2014 - 01/2004
9Epilepsy (Aura)
02/2014 - 09/2009
7Dyskinesias (Dyskinesia)
02/2012 - 07/2002
6Parkinsonian Disorders (Parkinsonism)
09/2015 - 09/2003
6Neurodegenerative Diseases (Neurodegenerative Disease)
10/2014 - 08/2005
6Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
10/2014 - 05/2002
6Tauopathies
03/2014 - 11/2005
6Seizures (Seizure)
01/2013 - 06/2008
6Alzheimer Disease (Alzheimer's Disease)
12/2011 - 08/2002
5Disease Progression
10/2014 - 09/2003
4Dementia (Dementias)
10/2014 - 01/2010
4Generalized Epilepsy
02/2014 - 11/2004
3Myasthenia Gravis
12/2014 - 03/2007
3Movement Disorders (Movement Disorder)
01/2014 - 10/2003
3Multiple Sclerosis
10/2013 - 03/2002
3Tremor (Tremors)
01/2010 - 09/2003
2Nausea
01/2014 - 10/2010
2Neoplasms (Cancer)
01/2014 - 01/2013
2Multiple System Atrophy
07/2013 - 01/2010
2REM Sleep Behavior Disorder
04/2013 - 03/2008
2Inflammation
01/2013 - 12/2005
2Autoimmune Diseases (Autoimmune Disease)
01/2013 - 03/2009
2Dystonia (Limb Dystonia)
06/2012 - 01/2010
2Schizophrenia (Dementia Praecox)
12/2011 - 06/2011
2Pain (Aches)
10/2011 - 03/2007
2Migraine Disorders (Migraine)
06/2011 - 02/2009
2Temporal Lobe Epilepsy
02/2010 - 09/2009
1Gaucher Disease (Gaucher's Disease)
09/2015
1Primary Progressive Aphasia
10/2014
1Nervous System Diseases (Neurological Disorders)
10/2014
1Glioma (Gliomas)
01/2014
1Brain Neoplasms (Brain Tumor)
01/2014

Drug/Important Bio-Agent (IBA)

16Levodopa (L Dopa)FDA LinkGeneric
02/2015 - 05/2002
11Dopamine Agonists (Dopamine Agonist)IBA
07/2014 - 05/2002
9pramipexol (pramipexole)FDA LinkGeneric
07/2014 - 01/2004
81- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2015 - 06/2011
8N 0437FDA Link
01/2012 - 12/2004
6Oxidopamine (6 Hydroxydopamine)IBA
05/2015 - 11/2003
6Anticonvulsants (Antiepileptic Drugs)IBA
02/2014 - 12/2008
5Dopamine (Intropin)FDA LinkGeneric
04/2014 - 07/2004
52- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
03/2009 - 09/2003
5Dopamine Agents (Dopaminergic Agents)IBA
01/2007 - 05/2002
4AutoantibodiesIBA
10/2014 - 03/2007
4alpha-SynucleinIBA
08/2014 - 09/2005
4Biological Markers (Surrogate Marker)IBA
10/2013 - 01/2010
4Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
10/2013 - 10/2003
4Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
10/2013 - 12/2002
4CytokinesIBA
04/2011 - 11/2003
3AntibodiesIBA
10/2014 - 08/2002
3annonacinIBA
03/2014 - 07/2007
3tolcapone (Tasmar)FDA Link
01/2014 - 01/2008
3Amyloid (Amyloid Fibrils)IBA
07/2013 - 09/2003
3Carbamazepine (Tegretol)FDA LinkGeneric
01/2011 - 12/2008
2Phosphotransferases (Kinase)IBA
05/2015 - 12/2012
2tyrosine receptor (receptor, tyrosine)IBA
05/2015 - 12/2012
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2014 - 03/2009
2Immunoglobulins (Immunoglobulin)IBA
12/2014 - 08/2002
2Immunoglobulin M (IgM)IBA
10/2014 - 10/2013
2Immunoglobulin A (IgA)IBA
10/2014 - 10/2013
2Immunoglobulin G (IgG)IBA
10/2014 - 10/2013
2ropinirole (Requip)FDA LinkGeneric
07/2014 - 01/2008
2EnzymesIBA
01/2014 - 07/2008
2tau Proteins (tau Protein)IBA
01/2014 - 11/2005
2Hydroxyl RadicalIBA
01/2014 - 08/2005
2Carbon MonoxideIBA
12/2013 - 02/2010
2Adenosine Triphosphate (ATP)IBA
12/2013 - 07/2007
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2013 - 02/2012
2GhrelinIBA
01/2013 - 06/2011
2perampanelIBA
01/2013 - 02/2012
2AntigensIBA
01/2013 - 03/2002
2Neuregulin-1 (Neuregulin 1)IBA
12/2012 - 06/2011
2etiracetam (levetiracetam)FDA LinkGeneric
11/2012 - 11/2004
2neuromelaninIBA
02/2011 - 01/2007
2Immunoglobulin E (IgE)IBA
02/2010 - 03/2008
2IronIBA
01/2010 - 12/2008
2Proteins (Proteins, Gene)IBA
01/2009 - 11/2004
2coenzyme Q10 (CoQ10)IBA
05/2008 - 07/2007
2cabergolineFDA LinkGeneric
01/2008 - 08/2003
2Pergolide (Permax)FDA Link
01/2008 - 03/2006
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
07/2005 - 05/2002
1noncerebral juvenile Gaucher diseaseIBA
09/2015
1Glucosylceramidase (Glucocerebrosidase)IBA
09/2015
1IgA receptor (protein B)IBA
10/2014
1N-Methylaspartate (NMDA)IBA
10/2014
1Piribedil (Trivastal)IBA
07/2014
1Selegiline (E250)FDA LinkGeneric
04/2014
1Sodium Channels (Sodium Channel)IBA
02/2014
1Idoxuridine (Stoxil)FDA LinkGeneric
01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1piericidin AIBA
01/2014
1Chaperonin 60IBA
01/2014

Therapy/Procedure

5Transplants (Transplant)
01/2014 - 07/2002
5Transplantation (Transplant Recipients)
04/2012 - 07/2002
3Deep Brain Stimulation
06/2013 - 07/2008
3Transdermal Patch
10/2010 - 12/2008
3Drug Therapy (Chemotherapy)
01/2010 - 07/2005
2Ketogenic Diet
09/2013 - 01/2011
1Plasmapheresis
12/2014
1Immunotherapy
10/2014